DAVID ALAN RANDOLPH, Registered Agent
Bremiga Therapeutics (operating as Brenig Therapeutics) is a biotechnology company developing small-molecule therapies for neurodegenerative diseases, specifically LRRK2 inhibitors targeting Parkinson's disease. The company's website highlights its pipeline and leadership team, including a CEO and Chief Medical Officer. The principal address is in Lakewood, Colorado.
Filed January 1, 2026 · Lakewood, CO
Your competitors in Lakewood are getting unlimited new business leads.
Bremiga Therapeutics, LLC is a biotechnology business (LLC) registered on January 1, 2026 with the Colorado Division of Corporations. Its principal address is 2067 S Robb Way, Lakewood, CO 80227-1965. The filing lists DAVID ALAN RANDOLPH as Registered Agent.
Get owner name, phone, email, and website for newly registered businesses delivered to your inbox daily.
Start Your Free Trial ›Filing timeline will be available soon.
Bremiga Therapeutics, LLC was registered as LLC on January 1, 2026 in Colorado.
Bremiga Therapeutics, LLC's principal address on file is 2067 S Robb Way, Lakewood, CO, 80227-1965.
Bremiga Therapeutics, LLC is classified as a biotechnology business (neurodegenerative disease therapeutics).
No EIN was found on file for Bremiga Therapeutics, LLC at the time of registration.
Based on the business category, these service providers typically target this type of business.